|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.086 AUD | -4.44% |
|
-7.53% | -40.69% |
| Apr. 17 | Impedimed Implements Organizational Changes; Makes Strategy Chief, COO Redundant | MT |
| Apr. 17 | Ord Minnett Starts ImpediMed at Speculative Buy, Price Target is AU$0.16 | MT |
ImpediMed Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported revenue was AUD 4.78 million compared to AUD 5.66 million a year ago. Net loss was AUD 9.72 million compared to AUD 10.82 million a year ago.
Basic loss per share from continuing operations was AUD 0.005 compared to AUD 0.006 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -40.69% | 113M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B | |
| +26.76% | 32.03B |
IMPEDIMED LIMITED 
